Cite
Terryn W, Vanholder R, Hemelsoet D, et al. Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT. JIMD Rep. 2012;8:101-8doi: 10.1007/8904_2012_167.
Terryn, W., Vanholder, R., Hemelsoet, D., Leroy, B. P., Van Biesen, W., De Schoenmakere, G., Wuyts, B., Claes, K., De Backer, J., De Paepe, G., Fogo, A., Praet, M., & Poppe, B. (2013). Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT. JIMD reports, 8101-8. https://doi.org/10.1007/8904_2012_167
Terryn, W, et al. "Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT." JIMD reports vol. 8 (2013): 101-8. doi: https://doi.org/10.1007/8904_2012_167
Terryn W, Vanholder R, Hemelsoet D, Leroy BP, Van Biesen W, De Schoenmakere G, Wuyts B, Claes K, De Backer J, De Paepe G, Fogo A, Praet M, Poppe B. Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT. JIMD Rep. 2013;8:101-8. doi: 10.1007/8904_2012_167. Epub 2012 Jul 29. PMID: 23430526; PMCID: PMC3565658.
Copy
Download .nbib